Skip to content

Early Intervention in Cognitive Aging

Early Intervention in Cognitive Aging

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02751866
Enrollment
250
Registered
2016-04-26
Start date
2016-01-31
Completion date
2026-06-30
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight, Obesity and Other Hyperalimentation (E65-E68)

Brief summary

Nutritional intervention in overweight middle aged individuals with subjective memory complaints.

Detailed description

Late-onset AD develops over many years during a preclinical period in which neuropathological changes accumulate before dementia is evident. Deposition of amyloid-beta (Aβ) in the brain is the earliest recognized biomarker of AD pathology, and, demographically, Aβ accumulation begins to accelerate at age 50, a period when the incidence of metabolic disturbance increases as well. Hyperinsulinemia associated with insulin receptor resistance has been associated with AD pathololgy, and metabolic disturbance in mid-life increases risk for subsequent dementia. There are indications that subjective memory complaints can be an early indicator of developing neuropathology and may be the first manifestation of future dementia. This research involves intervention studies in different samples of individuals from this population to investigate the extent to which berry fruit supplementation and ketone metabolism might improve cognitive performance in association with enhancement of metabolic function and related factors. The ultimate goal of this research is to develop interventional approaches that might be applied with at-risk individuals in the preclinical period of dementia to forestall or prevent progression of neurocognitive decline.

Interventions

DIETARY_SUPPLEMENTBerry fruit powder OR nutritional ketosis

Daily supplementation with berry fruit powder OR carbohydrate restriction to achieve nutritional ketosis

DIETARY_SUPPLEMENTPlacebo powder OR higher carbohydrate

Daily supplementation with placebo powder OR higher carbohydrate intake

Sponsors

University of Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

There is no blind in the dietary intervention given that participants are aware of the nature of the foods they consume. However, each dietary approach is described as healthy. In the berry supplementation studies, there is double blinding using berry fruit and placebo powders that are packaged with a code.

Intervention model description

Intervention with carbohydrate restriction designed to produce adaptation to ketone metabolism OR intervention with berry fruit powder supplementation.

Eligibility

Sex/Gender
ALL
Age
50 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* overweight; subjective memory complaints

Exclusion criteria

* diabetes; liver or kidney disease; age-related memory disorder; neurologic or psychiatric condition; substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Insulin resistanceEight or 12 weeks after enrollmentHOMA-IR will be derived from fasting glucose and insulin
Cognitive functionEight or 12 weeks after enrollmentPerformances on examiner-adminstered instruments assessing memory function

Secondary

MeasureTime frameDescription
Long term glucose concentrationEight or 12 weeks after enrollmentGlycated hemoglobin value

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026